BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 6217243)

  • 1. In vivo development of cytolytic T lymphocytes (CTL) to hapten-altered self: MIs-disparate cells facilitate the response by neutralizing IL 2 inhibitor.
    Gautam SC; Hilfiker ML; Battisto JR
    J Immunol; 1983 Feb; 130(2):533-7. PubMed ID: 6217243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance to Mls-disparate cells induces suppressor T cells that act at the helper level to prevent in vivo generation of cytolytic lymphocytes to hapten-altered self.
    Vargo PM; Battisto JR
    J Immunol; 1984 Jun; 132(6):2796-801. PubMed ID: 6233362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic control of hapten-reactive helper T-cell responses and its implications for the generation of augmented antitumor cytotoxic responses.
    Mizushima Y; Fujiwara H; Takai Y; Shearer GM; Hamaoka T
    J Natl Cancer Inst; 1985 Jun; 74(6):1269-73. PubMed ID: 3158772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of cytotoxic T lymphocyte development by a minor stimulating locus-induced suppressor cascade that involves Lyt-1+ suppressor T cells, IA- macrophages, and their factors.
    Chow KP; Battisto JR
    J Immunol; 1988 Feb; 140(4):1005-13. PubMed ID: 2963857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Ir gene control of cytotoxic response to hapten-modified self: helper T cells specific for a sulfhydryl hapten can substitute for an anti-TNP-H-2b self helper cell defect.
    Fujiwara H; Levy RB; Shearer GM
    J Immunol; 1981 Sep; 127(3):940-5. PubMed ID: 6167635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two distinct suppressor T cells acting in concert cause suppression of cytolytic T lymphocyte (CTL) response to hapten-altered self in vivo.
    Gautam SC; Beckman KD; Wong HL; Battisto JR
    J Immunol; 1983 Jun; 130(6):2557-60. PubMed ID: 6222107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-H-2-linked genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. I. Non-H-2-linked Ir gene defect expressed on T cells is not predetermined at the stage of bone marrow cells.
    Ogata M; Shimizu J; Tsuchida T; Takai Y; Fujiwara H; Hamaoka T
    J Immunol; 1986 Feb; 136(4):1178-85. PubMed ID: 2935573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-H-2-associated genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. Effect on the magnitude of secondary response and helper T cell generation after in vivo priming.
    Fujiwara H; Shearer GM
    Eur J Immunol; 1981 Sep; 11(9):700-4. PubMed ID: 6975212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of anti-hapten T cell cytotoxicity in vivo. Relationship to contact sensitivity and the role of contrasuppression.
    Ptak W; Friedman AM; Flood PM
    Arch Immunol Ther Exp (Warsz); 1994; 42(3):185-92. PubMed ID: 7487350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feeding trinitrochlorobenzene inhibits development of hapten-specific cytotoxic T lymphocytes by interfering with helper T-cell function.
    Gautam SC; Battisto JR
    Reg Immunol; 1989; 2(1):33-41. PubMed ID: 2534947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo regulation of the cytolytic T cell response to hapten-altered self: suppressor T cells induced in the regional lymph nodes by exposure to syngeneic spleen cells.
    Wong HL; Battisto JR
    Eur J Immunol; 1984 Jul; 14(7):629-33. PubMed ID: 6235115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell responses induced by the parenteral injection of antigen-modified syngeneic cells. II. Mechanisms, specificity, and cellular analysis of 2,4,6-trinitrophenol (TNP)-specific cytolytic response priming by intravenous versus subcutaneous injection with TNP-modified syngeneic cells.
    Miller SD; Butler LD; Cleveland RP; Moorhead JW; Claman HN; Chiller JC
    Cell Immunol; 1983 Dec; 82(2):378-93. PubMed ID: 6197193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses.
    Miller SD; Butler LD
    J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hapten epitope structure and hapten-self conjugation pattern on T cell specificity and Ir gene control in hapten-self cytotoxic and helper T cell responses.
    Takai Y; Mizuochi T; Fujiwara H; Hamaoka T
    J Immunol; 1984 Jan; 132(1):57-62. PubMed ID: 6197460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the hapten-specific T cell response. I. Preferential induction of hyporesponsiveness to the D-end of the major histocompatibility complex in the hapten-specific cytotoxic T cell response.
    Scott CF; Tsurufuji M; Benacerraf B; Sy MS
    J Immunol; 1983 Nov; 131(5):2184-9. PubMed ID: 6195256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helper cell analysis in cytotoxic T lymphocyte responses. I. Activation of specific and cross-reactive helper effects in two hapten-modified self responses.
    Levy RB; Fujiwara H; Shearer GM
    Eur J Immunol; 1980 Dec; 10(12):904-7. PubMed ID: 6162647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.
    Fujiwara H; Yoshioka T; Shima J; Kosugi A; Itoh K; Hamaoka T
    J Immunol; 1986 Apr; 136(7):2715-9. PubMed ID: 3005417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unresponsiveness in hapten-specific cytotoxic T lymphocytes. I. Characteristics of tolerance induction in adult mice.
    Butler LD; Miller SD; Claman HN
    J Immunol; 1981 Oct; 127(4):1383-7. PubMed ID: 6168687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The specificity of in vivo tolerance to haptens in NZB and normal mice after exposure to hapten-modified syngeneic spleen cells.
    Cowdery JS; Laskin CA; Steinberg AD
    J Immunol; 1982 Apr; 128(4):1571-6. PubMed ID: 6174607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The augmentation of tumor-specific immunity by virus help. I. Demonstration of vaccinia virus-reactive helper T cell activity involved in enhanced induction of cytotoxic T lymphocyte and antibody responses.
    Fujiwara H; Shimizu Y; Takai Y; Wakamiya N; Ueda S; Kato S; Hamaoka T
    Eur J Immunol; 1984 Feb; 14(2):171-5. PubMed ID: 6199215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.